PERFECTING THE ART OF FACIAL REJUVENATION - Optimizing Outcomes in Patients After Weight-Loss

Please Note: This CME activity has expired. You may continue to view the material for educational purposes, but this activity is no longer eligible for CME credit.

Course Objectives:

This educational activity is designed for intermediate to advanced dermatologists, plastic surgeons, aesthetic surgeons, oculoplastic surgeons and facial plastic surgeons who practice aesthetic medicine.

Upon completing this CME-certified case study, participants should be able to:


  • Compare and contrast the safety and efficacy of available dermal fillers and neurotoxins

  • Discuss the use of hyaluronic acid fillers in combination with botulinum toxin type A to optimize patient outcomes during facial rejuvenation procedures

  • Describe proper injection techniques based on facial zones to optimize outcomes and minimize adverse events

Accreditation:

Millennium CME Institute, Inc., is accredited by the Accreditation Council Continuing Medical Education to provide continuing medical education for physicians.

Millennium CME Institute, Inc., designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 2008-06-01
Expiration Date: 2009-06-30

© 2008 Millennium CME Institute, Inc. All rights reserved including translation into other languages. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems, without permission in writing from Millennium CME Institute, Inc.

Faculty Disclosure:

Arnold W. Klein, MD
Professor of Medicine and Dermatology
Founder, Arnold W. Klein Chair in Dermatology
David Geffen School of Medicine at UCLA, Los Angeles, California

Dr. Arnold William Klein, an internationally renowned dermatologist, is a world authority on minimally invasive aesthetics. Arnold Klein maintains an active private practice in Beverly Hills, CA, where he has been for more than 30 years. He is a Professor of Medicine and Dermatology at the David Geffen School of Medicine at UCLA, and has been honored with the establishment of the Arnold W. Klein Chair of Dermatology at UCLA, where he is a member of the academic and clinical staff. He is also an attending physician at the Cedars-Sinai Medical Center in Los Angeles.

Dr. Klein is a prolific writer and author; he has published nearly 150 scientific papers in such prestigious peer-reviewed journals as the New England Journal of Medicine, Science Magazine and JAMA. He has written four medical textbooks, including his most recent, "Tissue Augmentation in Clinical Practice", second Ed. Additionally, he has written numerous textbook chapters on Cosmetic Dermatology, Soft Tissue Augmentation, Aesthetic Surgery and Botulinum Toxin. In addition, he serves on the Editorial Board and as Expert Reviewer of numerous national and international medical publications, among them, the Journal of Plastic and Reconstructive Surgery, Journal of the American Academy of Dermatology, Dermatologic Surgery, Archives of Dermatology, Aesthetic Surgery, Aesthetic Buyers Guide, British Journal of Dermatology and the Journal of Cutaneous Aging and Cosmetic Dermatology, to name but a few. Over the years, Dr. Klein has also served as an advisor, consultant and Principal Investigator to Allergan, Anika, Elan Pharmaceuticals, Ethicon, Genzyme, Johnson & Johnson, Medicis Aesthetics, Ortho-Neutrogena, Skin-Medica and Q-Med.

Faculty Disclosure:

Millennium CME Institute, Inc., endorses the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support. All faculty are required to disclose any commercial relationships or personal benefit with companies whose products are discussed in educational presentations and with companies who have provided the commercial support for this activity. Disclosure of a relationship is not intended to suggest or condone bias in any presentation, but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. The faculty listed below, have declared that they have no relationships to disclose:

Signed disclosure forms are on file at Millennium CME Institute, Inc.

The opinions expressed in this publication are those of the participating faculty and do not necessarily reflect the opinions or the recommendations of their affiliated institutions, Millennium CME Institute, Inc., or any other persons. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this publication should not be used by clinicians without evaluation of their patients' conditions, assessment of possible contraindications or dangers in use, review of any applicable manufacturer's product information, and comparison with the recommendations of other authorities.

This Interactive Case Study is made possible through an educational grant from Allergan.

This CME-certified activity contains information on commercial products/devices that are unlabeled for use.

Directions:

The participant should read the learning objectives and review the activity in its entirety. After reviewing the material, the participant should complete the Activity Self-assessment Test consisting of a series of multiple-choice questions.

Upon successfully completing this activity as designed and achieving a passing score of 70% or higher on the Activity Self-assessment Test, participants will receive a continuing education credit letter awarding the appropriate credit and the Activity Self-assessment Test answers four to six weeks after the receipt of the registration and evaluation materials.

Estimated time to complete this activity as designed is 1.0 hours.